| Literature DB >> 22745815 |
Benedikt Klauke1, Bernward Winter, Agnes Gajewska, Peter Zwanzger, Andreas Reif, Martin J Herrmann, Andrea Dlugos, Bodo Warrings, Christian Jacob, Andreas Mühlberger, Volker Arolt, Paul Pauli, Jürgen Deckert, Katharina Domschke.
Abstract
The etiology of emotion-related disorders such as anxiety or affective disorders is considered to be complex with an interaction of biological and environmental factors. Particular evidence has accumulated for alterations in the dopaminergic and noradrenergic system--partly conferred by catechol-O-methyltransferase (COMT) gene variation--for the adenosinergic system as well as for early life trauma to constitute risk factors for those conditions. Applying a multi-level approach, in a sample of 95 healthy adults, we investigated effects of the functional COMT Val158Met polymorphism, caffeine as an adenosine A2A receptor antagonist (300 mg in a placebo-controlled intervention design) and childhood maltreatment (CTQ) as well as their interaction on the affect-modulated startle response as a neurobiologically founded defensive reflex potentially related to fear- and distress-related disorders. COMT val/val genotype significantly increased startle magnitude in response to unpleasant stimuli, while met/met homozygotes showed a blunted startle response to aversive pictures. Furthermore, significant gene-environment interaction of COMT Val158Met genotype with CTQ was discerned with more maltreatment being associated with higher startle potentiation in val/val subjects but not in met carriers. No main effect of or interaction effects with caffeine were observed. Results indicate a main as well as a GxE effect of the COMT Val158Met variant and childhood maltreatment on the affect-modulated startle reflex, supporting a complex pathogenetic model of the affect-modulated startle reflex as a basic neurobiological defensive reflex potentially related to anxiety and affective disorders.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22745815 PMCID: PMC3382176 DOI: 10.1371/journal.pone.0039709
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Descriptive characteristics of probands by sex, challenge condition and COMT Val158Met genotype.
| Male | Female | Caffeine | Placebo | ||||||||||||
| Variable | N | Mean | SD | N | Mean | SD | N | Mean | SD | N | Mean | SD | N | Mean | SD |
|
| |||||||||||||||
| Age (years) | 90 | 26.46 | 6.22 | 45 | 27.00 | 5.93 | 45 | 25.91 | 6.51 | 43 | 25.98 | 5.29 | 42 | 26.60 | 6.80 |
| CTQ (sum) | 90 | 33.23 | 5.60 | 45 | 32.71 | 4.66 | 45 | 33.76 | 6.41 | 43 | 32.88 | 5.51 | 42 | 33.57 | 5.92 |
| ITI startle | 89 | 37.29 | 26.46 | 44 | 35.55 | 26.26 | 45 | 39.00 | 26.84 | 43 | 35.54 | 24.76 | 41 | 39.66 | 28.51 |
| Startle unpl | 90 | 51.38 | 2.62 | 45 | 50.57 | 2.26 | 45 | 52.19 | 2.73 | 43 | 51.45 | 3.03 | 42 | 51.24 | 2.19 |
| Startle pl | 90 | 48.64 | 1.79 | 45 | 48.91 | 1.50 | 45 | 48.38 | 2.02 | 43 | 48.68 | 1.89 | 42 | 48.81 | 1.69 |
| Diffunpl-neutr | 90 | 1.42 | 4.48 | 45 | −0.01 | 3.90 | 45 | 2.85 | 4.61 | 43 | 1.58 | 5.16 | 42 | 1.30 | 3.76 |
|
| |||||||||||||||
|
| |||||||||||||||
| Age (years) | 15 | 25.47 | 4.87 | 6 | 26.17 | 4.54 | 9 | 25.00 | 5.29 | 7 | 26.29 | 4.35 | 6 | 23.17 | 0.98 |
| CTQ (sum) | 15 | 32.87 | 4.24 | 6 | 33.83 | 3.97 | 9 | 32.22 | 4.52 | 7 | 32.86 | 2.85 | 6 | 33.00 | 5.97 |
| ITI startle | 15 | 36.13 | 23.95 | 6 | 23.69 | 21.76 | 9 | 44.42 | 22.68 | 7 | 34.49 | 24.27 | 6 | 31.09 | 22.75 |
| Startle unpl | 15 | 53.16 | 2.14 | 6 | 52.72 | 0.99 | 9 | 53.45 | 2.68 | 7 | 53.50 | 2.48 | 6 | 52.77 | 2.23 |
| Startle pl | 15 | 48.02 | 1.69 | 6 | 48.23 | 1.07 | 9 | 47.87 | 2.05 | 7 | 48.17 | 1.29 | 6 | 48.46 | 2.07 |
| Diffunpl-neutr | 15 | 4.41 | 3.99 | 6 | 3.75 | 1.96 | 9 | 4.84 | 4.99 | 7 | 5.22 | 5.24 | 6 | 3.99 | 2.95 |
|
| |||||||||||||||
| Age (years) | 42 | 25.83 | 6.07 | 22 | 26.45 | 5.79 | 20 | 25.15 | 6.45 | 22 | 24.45 | 3.46 | 20 | 27.35 | 7.86 |
| CTQ (sum) | 42 | 33.40 | 6.01 | 22 | 33.27 | 5.13 | 20 | 33.55 | 6.98 | 22 | 33.05 | 6.27 | 20 | 33.80 | 5.85 |
| ITI startle | 41 | 34.00 | 19.95 | 21 | 34.60 | 18.38 | 20 | 33.36 | 21.95 | 22 | 30.61 | 15.89 | 19 | 37.91 | 23.66 |
| Startle unpl | 42 | 50.89 | 2.79 | 22 | 50.29 | 2.54 | 20 | 51.56 | 2.97 | 22 | 50.86 | 3.32 | 20 | 50.93 | 2.15 |
| Startle pl | 42 | 49.28 | 1.81 | 22 | 49.13 | 1.57 | 20 | 49.44 | 2.07 | 22 | 49.41 | 2.04 | 20 | 49.12 | 1.55 |
| Diffunpl-neutr | 42 | 1.00 | 4.73 | 22 | −0.42 | 4.43 | 20 | 2.56 | 4.65 | 22 | 1.07 | 5.47 | 20 | 0.92 | 3.89 |
|
| |||||||||||||||
| Age (years) | 33 | 27.70 | 6.88 | 17 | 28.00 | 6.67 | 16 | 27.38 | 7.29 | 14 | 28.21 | 7.28 | 16 | 26.94 | 6.50 |
| CTQ (sum) | 33 | 33.18 | 5.75 | 17 | 31.58 | 4.26 | 16 | 34.88 | 6.72 | 14 | 32.64 | 5.54 | 16 | 33.50 | 6.37 |
| ITI startle | 33 | 41.92 | 33.77 | 17 | 40.90 | 34.62 | 16 | 43.01 | 33.95 | 14 | 43.80 | 34.44 | 16 | 44.95 | 35.50 |
| Startle unpl | 33 | 51.19 | 2.31 | 17 | 50.17 | 1.82 | 16 | 52.28 | 2.32 | 14 | 51.36 | 2.46 | 16 | 51.06 | 2.13 |
| Startle pl | 33 | 48.12 | 1.57 | 17 | 48.87 | 1.53 | 16 | 47.33 | 1.22 | 14 | 47.77 | 1.43 | 16 | 48.54 | 1.75 |
| Diffunpl-neutr | 33 | 0.59 | 3.90 | 17 | −0.82 | 2.94 | 16 | 2.08 | 4.31 | 14 | 0.55 | 4.06 | 16 | 0.77 | 3.63 |
ITI startle = startle response during the intertrial interval in µV (ITI); Startle unpl = startle response after presentation of unpleasant IAPS pictures (in µV; T-transformed); Startle pl = startle response after presentation of pleasant IAPS pictures (in µV; T-transformed); Diffunpl-neutr = potentiation of startle magnitude by unpleasant IAPS pictures (in µV; T-transformed values: contrast unpleasant/neutral pictures); CTQ = Childhood Trauma Questionnaire (sum score).
Note: Because of the large variance of caffeine saliva concentrations (difference of more than one and a half interquartile ranges from the respective median in the placebo or verum group) five subjects were excluded, leaving 85 subjects for further analyses when considering challenge condition. For the mean ITI startle response, one subject was excluded because of an extreme score (> three SD).
Figure 1Mean startle magnitude modulated by picture category and COMT Val158Met genotype.
*** significant at significance level of p≤.005.
Figure 2Linear regression analysis of CTQ sum score influence on startle magnitude potentiation after unpleasant and pleasant IAPS pictures stratified by COMT Val158Met genotype.
Results of hierarchical multiple regression analysis regarding affect-modulated startle magnitude (contrast unpleasant/neutral IAPS pictures; Diffunpl-neutr).
|
|
|
| |||||||
| Predictors |
| Δ | Δ |
|
|
|
|
|
|
|
| .191 |
|
| ||||||
| sex | .31 |
| .33 |
| −6.10 | −1.62 | |||
|
| .27 |
| −5.28 |
| −3.83 | −1.36 | |||
| CTQ | −.12 | −1.20 | .14 | .90 | .02 | .13 | |||
|
| .232 |
|
| ||||||
|
| 5.57 |
| 4.15 | 1.48 | |||||
|
| .263 | .030 | 1.13 (.342) | ||||||
|
| −4.23 | −1.12 | |||||||
| CTQ x sex | 6.37 | 1.69 | |||||||
|
| 4.14 | 1.10 | |||||||
COMT (val/val) = val/val vs. val/met and met/met genotypes; CTQ = Childhood Trauma Questionnaire (logarithmized sum score); R 2 = coefficient of determination (explained variance); ΔR 2 = increase of explained variance; ΔF (p) = change and significance of F-statistics; β = standardized regression coefficient; t = t-statistics.
p<0.01 (bold); * p<0.05 (bold).